多草药配方的神经保护潜力:来自初步体外和体外研究的证据
Kundlik Rathod1, Aswar Urmila1
1Department of Pharmacology, Poona College of Pharmacy, Bharati Vidyapeeth (Deemed to be University), Erandwane, Pune, Maharashtra, 411038, India.
Biochemistry and biophysics reports
|December 24, 2025
概括
这项研究开发了一种用于帕金森病 (PD) 的多草药配方 (PHF),使用七种药用植物. PHF表现出显著的抗氧化,抗炎和MAO-B抑制活性,表明神经元保护的治疗潜力.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 草药是一种草药.
背景情况:
- 帕金森病 (PD) 是一种进展性神经退行性疾病.
- 目前的治疗方法可以缓解症状,但不能阻止疾病的进展.
- 需要针对神经保护的新型治疗策略.
研究的目的:
- 开发和评估用于帕金森病 (PD) 的多草药配方 (PHF).
- 研究PHF的抗氧化,抗炎和MAO-B抑制性质.
- 评估PHF的安全情况.
主要方法:
- 文献调查和七种药用植物的选择.
- 制备和评估酒提取物.
- PHF的配方和物理化学性质和生物活性成分 (HPTLC) 的评估.
- 在体外测定抗氧化剂,抗炎药物和MAO-B抑制.
- 分子对接研究. 分子对接研究.
- 急性口服毒性评估 (经合组织425指南).
主要成果:
- 选择了四种强效的植物提取物 (白, Convolvulus prostratus, Bacopa monnieri, Nigella sativa) 进行研究.
- HPTLC证实了关键生物活性化合物的存在,如奎尔丁,凯姆菲罗尔,鲁丁和β-固醇.
- PHF表现出显著的抗氧化,抗炎和MAO-B抑制活性.
- 分子对接表明了与PD相关目标的潜在相互作用.
- 在急性口服毒性研究中,PHF表现出良好的安全性.
结论:
- 开发的多草药配方 (PHF) 显示了对帕金森病的有前途的治疗潜力.
- 观察到的抗氧化,抗炎和MAO-B抑制活性支持其神经保护作用.
- PHF是安全的口服,需要进一步的临床研究.
相关概念视频
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
01:29Drug Delivery: Parenteral Route
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...